- Home
- ENLV vs FLGC Comparison
ENLV vs FLGC Comparison
Compare ENLV & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- FLGC
- Stock Information
- Founded
- ENLV 2005
- FLGC 2019
- Country
- ENLV Israel
- FLGC United States
- Employees
- ENLV N/A
- FLGC N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- ENLV Health Care
- FLGC Health Care
- Exchange
- ENLV Nasdaq
- FLGC Nasdaq
- Market Cap
- ENLV 31.5M
- FLGC 26.5M
- IPO Year
- ENLV 1995
- FLGC 2021
- Fundamental
- Price
- ENLV $1.09
- FLGC $1.27
- Analyst Decision
- ENLV Strong Buy
- FLGC Strong Buy
- Analyst Count
- ENLV 2
- FLGC 3
- Target Price
- ENLV $9.50
- FLGC $6.50
- AVG Volume (30 Days)
- ENLV 173.7K
- FLGC 533.4K
- Earning Date
- ENLV 11-30-2024
- FLGC 11-13-2024
- Dividend Yield
- ENLV N/A
- FLGC N/A
- EPS Growth
- ENLV N/A
- FLGC N/A
- EPS
- ENLV N/A
- FLGC N/A
- Revenue
- ENLV N/A
- FLGC $69,006,000.00
- Revenue This Year
- ENLV N/A
- FLGC N/A
- Revenue Next Year
- ENLV N/A
- FLGC $19.90
- P/E Ratio
- ENLV N/A
- FLGC N/A
- Revenue Growth
- ENLV N/A
- FLGC 13.06
- 52 Week Low
- ENLV $1.08
- FLGC $0.70
- 52 Week High
- ENLV $4.59
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- ENLV 27.79
- FLGC 42.50
- Support Level
- ENLV $1.13
- FLGC $1.11
- Resistance Level
- ENLV $1.33
- FLGC $1.63
- Average True Range (ATR)
- ENLV 0.10
- FLGC 0.17
- MACD
- ENLV -0.02
- FLGC -0.05
- Stochastic Oscillator
- ENLV 6.52
- FLGC 14.43
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.